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Amyotrophic lateral sclerosis (ALS) is a
fatal disease characterized by synaptic
failure. Coyne et al. show that in multiple
models of ALS, ranging from Drosophila
to mice to patient-derived motor neurons,
deficits in synaptic vesicle cycling can be
explained by dysregulation of the Hsc704/HSPA8 chaperone.
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SUMMARY

Amyotrophic lateral sclerosis (ALS) is a synaptopathy accompanied by the presence of cytoplasmic
aggregates containing TDP-43, an RNA-binding protein linked to 97% of ALS cases. Using a Drosophila
model of ALS, we show that TDP-43 overexpression
(OE) in motor neurons results in decreased expression of the Hsc70-4 chaperone at the neuromuscular
junction (NMJ). Mechanistically, mutant TDP-43 sequesters hsc70-4 mRNA and impairs its translation.
Expression of the Hsc70-4 ortholog, HSPA8, is also
reduced in primary motor neurons and NMJs of
mice expressing mutant TDP-43. Electrophysiology,
imaging, and genetic interaction experiments reveal
TDP-43-dependent defects in synaptic vesicle endocytosis. These deficits can be partially restored by
OE of Hsc70-4, cysteine-string protein (Csp), or dynamin. This suggests that TDP-43 toxicity results in
part from impaired activity of the synaptic CSP/
Hsc70 chaperone complex impacting dynamin function. Finally, Hsc70-4/HSPA8 expression is also posttranscriptionally reduced in fly and human induced
pluripotent stem cell (iPSC) C9orf72 models, suggesting a common disease pathomechanism.
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease linked to several genes, including SOD1 (Rosen
et al., 1993), TARDBP (TDP-43) (Kabashi et al., 2008; Sreedharan
et al., 2008), FUS (Kwiatkowski et al., 2009; Vance et al., 2009),
and C9orf72 (DeJesus-Hernandez et al., 2011; Renton et al.,

2011), suggesting the presence of multiple disease mechanisms
(Robberecht and Philips, 2013). Synaptic degeneration is a
culminating point in ALS, however, the molecular mechanisms
that trigger this remain poorly understood (Gillingwater and
Wishart, 2013).
With 2%–3% of ALS patients harboring mutations in TDP-43
(Kabashi et al., 2008; Neumann, 2009; Sreedharan et al., 2008;
Van Deerlin et al., 2008) and 97% of all ALS cases exhibiting
TDP-43 pathology (Ling et al., 2013), TDP-43 is a common denominator in ALS. Thus, elucidating the mechanisms by which
both wild-type and mutant TDP-43 cause neurodegeneration is
essential to our understanding of ALS pathogenesis.
TDP-43 is a nucleo-cytoplasmic shuttling, DNA/RNA-binding
protein containing a prion-like C-terminal domain where the majority of ALS-causing mutations cluster, causing an increase in
TDP-43’s intrinsic propensity for aggregation (Johnson et al.,
2009). TDP-43 was shown to bind UG-rich sequences and regulate the splicing of several transcripts encoding synaptic proteins
(Polymenidou et al., 2011; Sephton et al., 2011; Tollervey et al.,
2011). In addition, TDP-43 regulates the localization and translation of specific mRNAs (Alami et al., 2014; Coyne et al., 2014; Fallini et al., 2012). TDP-43 also associates with RNA stress granules (SGs), which sequester specific mRNAs, resulting in
translation inhibition (Dewey et al., 2011; Kim et al., 2014; LiuYesucevitz et al., 2010; McDonald et al., 2011).
TDP-43 has previously been shown to associate with human
Hsc70 (HSPA8) in mammalian cells (Freibaum et al., 2010).
Hsc70 proteins comprise a family of constitutive, ubiquitous molecular chaperones with roles in protein folding and degradation,
stress response, endosomal microautophagy, and chaperonemediated autophagy (Liu et al., 2012). Consistent with its role
in proteostasis, HSPA8 has been implicated in neurodegeneration as it colocalizes with ubiquitin-positive inclusions in sporadic
ALS (Watanabe et al., 2001). Among the multiple Hsc70 proteins
in Drosophila (Palter et al., 1986; Perkins et al., 1990), the clathrin-uncoating ATPase Hsc70-4 has roles in synaptic vesicle
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(SV) exo- and endocytosis, and it is highly expressed in neurons
and at the larval neuromuscular junction (NMJ) (Bronk et al.,
2001; Chang et al., 2002; Zinsmaier and Bronk, 2001).
The critical role of Hsc70-4 in SV cycling (SVC) led us to hypothesize that abnormal interactions between TDP-43 and
Hsc70-4 may lead to synaptic impairments prior to degeneration. Here we show that motor neuron overexpression (OE) of
TDP-43 causes a reduction in synaptic Hsc70-4 levels and impairments in SVC at the Drosophila NMJ. Using electrophysiology and FM1-43 dye uptake experiments, we show that defects in SVC are due to deficits in SV endocytosis. Similar to
our findings in Drosophila, we show that HSPA8 protein is
reduced post-transcriptionally at the NMJ in TDP-43A315T mice
and in TDP-43G298S, patient-derived, induced pluripotent stem
cell (iPSC) motor neurons. Furthermore, flies harboring 36
G4C2 repeats (Mizielinska et al., 2014) and C9orf72 patientderived iPSC motor neurons (Zhang et al., 2015) exhibit a
post-transcriptional reduction in Hsc70-4/HSPA8 protein.
Together, our findings uncover defects in SV endocytosis as a
source of synaptic dysfunction in TDP-43- and C9orf72-mediated ALS.
RESULTS
Hsc70-4 Protein and mRNA Form a Complex with TDP43 in Motor Neurons In Vivo
To test whether TDP-43 associates with Hsc70-4, we performed
immunoprecipitations (IPs) from Drosophila adults expressing
TDP-43 in motor neurons (Figure 1A) followed by mass
spectrometry (data not shown). We found that while Hsc70-4
associates with both wild-type TDP-43 (TDP-43WT) and ALSassociated mutant TDP-43 (TDP-43G298S; 22.9% and 30.1%
sequence coverage, respectively), its interaction with TDP43G298S is significantly stronger (Figure 1A). These results
confirm that endogenous Hsc70-4 associates with human
wild-type and mutant TDP-43 in Drosophila motor neurons.
To determine whether hsc70-4 mRNA is present in TDP-43
complexes, we performed RNA IPs (RIP) from Drosophila adults
expressing TDP-43WT or TDP-43G298S in motor neurons followed
by real-time qPCR. hsc70-4 mRNA was strongly enriched in

TDP-43G298S while less was present in TDP-43WT complexes
(Figure 1B).
It has been proposed that, under prolonged stress, TDP-43
may sequester its mRNA targets into insoluble complexes,
thereby preventing their translation and normal function (Ramaswami et al., 2013). To test whether TDP-43 sequesters hsc70-4
mRNA, we performed subcellular fractionations from Drosophila
larvae expressing TDP-43 in motor neurons. Using real-time
qPCR, we found an enrichment of hsc70-4 mRNA in the insoluble
fraction of animals expressing TDP-43G298S, but not TDP-43WT
(Figure 1C), consistent with hsc70-4 mRNA sequestration specifically by TDP-43G298S. These data show that both Hsc70-4
protein and its cognate mRNA associate with TDP-43, albeit
preferentially with TDP-43G298S.
OE of TDP-43G298S Inhibits the Translation of hsc70-4
mRNA
The sequestration of hsc70-4 mRNA by TDP-43G298S may impair
its translation. To test this possibility, we performed polysome
fractionations from adult Drosophila overexpressing TDP-43WT
or TDP-43G298S in motor neurons. Using real-time qPCR, we
found that TDP-43G298S OE resulted in a shift for hsc70-4
mRNA from actively translating polysomes to non-translated
(ribonucleoprotein particle [RNP]) fractions, while TDP-43WT
had no effect (Figures 1E and 1F). Given that no changes in overall hsc70-4 mRNA levels were detected in whole animals (Figure 1D), these data suggest that TDP-43G298S impairs the translation of hsc70-4 mRNA by sequestering it into insoluble RNPs.
In contrast, TDP-43WT did not affect hsc70-4 mRNA translation,
at least within the limits of sensitivity provided by this assay.
TDP-43 Expression Reduces Hsc70-4 Levels at the
Larval NMJ in Drosophila
The translation inhibition of hsc70-4 mRNA by TDP-43G298S predicts that Hsc70-4 levels are reduced, which in turn may impair
Hsc70-4’s function (Stricher et al., 2013; Uytterhoeven et al.,
2015; Zinsmaier and Bronk, 2001). No changes in protein
expression were found in extracts of whole larvae or dissected
ventral nerve cords (VNCs) from animals overexpressing TDP43WT or TDP-43G298S in motor neurons (Figures 1G, 1H, 1J,

Figure 1. hsc70-4 mRNA Is a Translation Target of TDP-43G298S, and Hsc70-4 Protein Expression Is Reduced at Synaptic Terminals of TDP43-Expressing Animals
(A) Immunoprecipitation (IP) of TDP-43 expressed in motor neurons. Genotypes and antibodies used for IP are indicated on the top. Antibodies used for western
blot (WB) are indicated on the right.
(B) qPCR for hsc70-4 mRNA in TDP-43 complexes.
(C) qPCR for hsc70-4 mRNA in soluble and insoluble TDP-43 complexes.
(D–F) qPCR for hsc70-4 mRNA in input (D), RNP (E), and polysomes (F) from flies expressing TDP-43WT and TDP-43G298S in motor neurons compared to controls.
(G) WB for Hsc70-4 levels in whole larvae expressing TDP-43 in motor neurons. Genotypes are indicated on the bottom. Actin was used as a loading control.
(H) Quantification of Hsc70-4 protein levels from WBs represented as a ratio to w1118 controls.
(I) qPCR for hsc70-4 mRNA in whole larvae of animals expressing TDP-43WT or TDP-43G298S in motor neurons versus controls.
(J) WB for Hsc70-4 levels in VNCs of TDP-43-expressing larvae. Genotypes are indicated on the bottom. Actin was used as a loading control.
(K) Quantification of Hsc70-4 protein levels from WBs represented as a ratio to w1118 controls.
(L) qPCR for hsc70-4 mRNA in VNCs of animals expressing TDP-43WT or TDP-43G298S in motor neurons versus controls.
(M–O) Single confocal sections of synaptic boutons in NMJ preparations immunostained for Hsc70-4 and the neuronal membrane marker Hrp from larvae
expressing TDP-43WT (N) and TDP-43G298S (O) compared to w1118 controls (M). Antibodies are indicated on the left.
(P) Quantification of Hsc70-4 intensity in synaptic boutons normalized to bouton area. Note p < 0.001 for TDP-43WT versus TDP-43G298S.
(Q) qPCR for hsc70-4 mRNA in NMJ preparations of animals expressing TDP-43WT or TDP-43G298S in motor neurons versus controls.
(R) Quantification of Hsc70-4 intensity in muscle normalized to muscle area.
All data shown are mean ± SEM. Scale bars, 5 and 1 mm (M–O).
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Figure 2. Hsc70/HSPA8 Expression Is Reduced in Mutant TDP-43-Expressing Mouse Primary Motor Neurons, at Synaptic Terminals of
Mouse NMJs, and in TDP-43G298S Human iPSC Neurons
(A–D) Representative fluorescence images of cell bodies from primary motor neurons transfected with expression constructs for GFP (A–A’’’) or GFP-tagged
TDP-43WT (B–B’’’), TDP-43Q331K (C–C’’’), or TDP-43M337V (D–D’’’), as indicated on the left. Antibodies and stains are indicated on the top.
(E–H) Representative fluorescence images of growth cones from primary motor neurons expressing GFP (E and E’) or GFP-tagged TDP-43WT (F and F’), TDP43Q331K (G and G’), or TDP-43M337V (H and H’), as indicated on the left. Antibodies are indicated on the top.
(I and J) Quantification of fluorescent intensity (a.u.) of Hsc70 in the cell body (I) and growth cones (J).
(K and L) Epifluorescent images of mouse NMJs immunostained for Hsc70/HSPA8 (K’ and L’) and AChR (K’’ and L’’). Genotypes are indicated on the left and
antibodies are indicated on the top.
(M) Quantification of Hsc70/HSPA8 intensity from NMJs.
(N) Confocal images of control and TDP-43G298S human iPSC motor neurons labeled with DAPI, the dendritic marker Map2, and Hsc70/HSPA8. Genotypes are
indicated on the left and antibodies are indicated on the top.
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and 1K). In contrast, immunostainings at NMJs revealed a significant decrease in Hsc70-4 within synaptic boutons in animals
overexpressing TDP-43WT and TDP-43G298S compared to controls (14% and 43% decrease, respectively, p < 0.001; Figures
1M–1P). Notably, muscle Hsc70-4 levels remained unchanged
(Figure 1R; Figures S1D–S1F). Since we found no changes in
transcript levels in extracts from whole larvae, VNCs, or NMJ
preparations (Figures 1I, 1L, and 1Q), our data suggest that
hsc70-4 mRNA is regulated by TDP-43 post-transcriptionally.
Although we cannot eliminate the possibility that Hsc70-4 protein transport or stability at the NMJ may be altered by TDP-43
OE, together with the polysome fractionation results, our findings
suggest that TDP-43G298S OE reduces Hsc70-4 levels cell autonomously by inhibiting hsc70-4 mRNA translation. While TDP43WT also decreases Hsc70-4 levels at synaptic terminals, this
appears to arise from a distinct mechanism.
OE of Disease-Associated Mutant TDP-43 Reduces
HSPA8 Levels in Mouse Primary Motor Neurons
Having identified reduced synaptic expression of Hsc70-4 in the
fly, we next asked if HSPA8 levels were also altered in a mammalian model of ALS. To evaluate HSPA8 levels, we transfected
mouse primary motor neurons with GFP-tagged TDP-43WT,
TDP-43Q331K, TDP-43M337V, or GFP alone, and we performed immunostainings for HSPA8. OE of TDP-43WT had no effect on
HSPA8 levels in growth cones or cell bodies (p > 0.05; Figures
2B, 2F, 2I, and 2J). In contrast, TDP-43Q331K or TDP-43M337V
OE significantly reduced HSPA8 levels in growth cones (by
39% and 41%, respectively, p < 0.01; Figures 2G, 2H, and 2J)
and cell bodies (12% decrease for TDP-43Q331K, p < 0.05; Figures 2C and 2I; 33% decrease for TDP-43M337V, p < 0.001; Figures 2D and 2I). These data indicate that, similar to what was
observed in the fly model, HSPA8 levels are reduced in mammalian primary motor neurons overexpressing disease-associated
mutant TDP-43.
HSPA8 Expression Is Reduced at the NMJ in TDP43A315T Mutant Mice
We next asked whether levels of HSPA8 are also reduced at
NMJs of TDP-43 mutant mice. To address this, dissected mouse
NMJs were immunostained for HSPA8 and postsynaptic acetylcholine receptors (AChRs). In comparison to controls, synaptic
HSPA8 immunoreactivity at NMJs expressing TDP-43A315T (Wegorzewska et al., 2009) was decreased by 21% (p < 0.05; Figures
2K–2M). Taken together, these data indicate that disease-associated mutant TDP-43 reduces levels of HSPA8 at NMJs of both
flies and mice.
HSPA8 Expression Is Reduced in TDP-43G298S Human
iPSC Motor Neurons
Next, we sought to determine if expression of HSPA8 was also
altered in human iPSC-derived motor neurons harboring the
TDP-43G298S mutation. Immunofluorescence experiments

showed a significant decrease in HSPA8 expression in the
soma and dendrites of TDP-43G298S iPSC motor neurons
compared to controls (Figures 2N and 2O). Notably, hspa8
mRNA expression was unchanged (Figure 2P), consistent with
post-transcriptional regulation of HSPA8 expression, as in the fly.
Hsc70-4 OE Mitigates TDP-43-Mediated Toxicity in Flies
To determine whether the reduced levels of Hsc70-4 at NMJs
contribute to the locomotor and lifespan defects induced by
TDP-43 OE in flies (Coyne et al., 2014, 2015; Estes et al., 2011,
2013), we co-overexpressed Hsc70-4 with either TDP-43WT or
TDP-43G298S in motor neurons, and we found that it significantly
improved locomotor function, as indicated by a faster turning
time (see the Experimental Procedures; Figure 3A). Co-OE of
Hsc70-4 also significantly increased lifespan from 33 to
45 days and from 28 to 55 days for TDP-43 WT and TDP43G298S animals, respectively (p < 0.001; Figures 3B and 3C).
Notably, suppression of TDP-43 toxicity by Hsc70-4 was not
due to a reduction in TDP-43 protein or mRNA levels (Figure S2).
As with TDP-43G298S, Hsc70-4 also suppressed the locomotor
dysfunction induced by OE of disease-associated TDP-43Q331K
or TDP-43M337V in Drosophila motor neurons (Figure S3C), which
supports the notion that different C terminus mutations in
TDP-43 employ similar mechanisms. Importantly, co-OE of the
Hsc70-4-related protein Hsc70-3 or the Hsc70-interacting protein Hsp90 (Hsp83) had no effect on TDP-43-induced locomotor
dysfunction (Figures S3D and S3E). Taken together, these findings suggest that a specific loss of synaptic Hsc70-4 activity underlies, at least in part, the toxic effects of wild-type or mutant
TDP-43 OE in Drosophila motor neurons.
Hsc70-4 is known to act as a molecular chaperone and is also
involved in endosomal microautophagy (Uytterhoeven et al.,
2015; Zinsmaier, 2010). To determine whether OE of TDP-43WT
or TDP-43G298S affects these functions, we co-overexpressed
TDP-43 with chaperone-dead (Hsc70-4D10N) or microautophagy-dead (Hsc70-43KA) Hsc70-4 (Uytterhoeven et al., 2015). In
contrast to the mitigating effect of Hsc70-4WT, co-OE of either
Hsc70-4D10N or Hsc70-43KA enhanced TDP-43WT- (Figure S3A)
and had no effect on TDP-43G298S-induced locomotor dysfunction (Figure S3B). Since Hsc70-4D10N or Hsc70-43KA OE alone
had no effect on locomotor activity (Figures S3A and S3B), these
results suggest that TDP-43 compromises both the molecular
chaperone and the endosomal microautophagy activities of
Hsc70-4.
OE of TDP-43 in Motor Neurons Impairs SV Endocytosis
Given the various critical synaptic roles of Hsc70-4 in SVC, such
as the uncoating of clathrin-coated SVs in cooperation with auxilin, maintaining SNARE complex assembly and dynamin oligomerization in cooperation with cysteine-string protein (Csp),
and degradation of synaptic proteins by endosomal microautophagy (Bronk et al., 2001; Burgoyne and Morgan, 2015; Chang
et al., 2002; Eisenberg and Greene, 2007; Uytterhoeven et al.,

(O) Quantification of Hsc70/HSPA8 intensity in the soma and dendrites of control and TDP-43G298S human iPSC motor neurons normalized to control. Symbols
represent mean of 25–30 neurons from each line (controls) or differentiation (TDP-43) and indicate differentiation pairs.
(P) qPCR for Hsc70/HSPA8 mRNA in control and TDP-43G298S human iPSC motor neurons.
All data shown are mean ± SEM. Scale bars, 10 mm (A and N) and 20 mm (K).
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Figure 3. TDP-43 Expression Results in Defects in SV Endocytosis that Are Suppressed by Hsc70-4 in a Variant-Dependent Manner
(A) Motor neuron expression of TDP-43WT or TDP-43G298S results in increased larval turning time, which is mitigated by OE of Hsc70-4.
(B and C) Motor neuron expression of TDP-43 variants WT (B) or G298S (C) leads to reduced lifespan. OE of Hsc70-4 increases lifespan for both TDP-43WT (B) and
TDP-43G298S (C).
(D) Representative electrophysiology traces of EJPs. Genotypes are indicated on the top.
(E–G) EJP amplitude (E), miniature EJP (mEJP) amplitude (F), and quantal content (G) measurements from electrophysiology recordings. Genotypes are indicated
on the bottom.
(H–P) Confocal images of FM1-43 dye uptake in synaptic boutons of Drosophila larvae after 5 min of stimulation in HL-3 saline containing 90 mM KCl and 2 mM
Ca2+. Genotypes are indicated on the top and left.
(Q) Quantification of FM1-43 dye uptake normalized to total FM1-43 uptake area. Note an 18% ± 1.8% reduction in FM1-43 dye uptake for TDP-43G298S, Hsc70-4
OE compared to w1118 controls (p < 0.001).
All data shown are mean ± SEM. Scale bar, 10 mm (D).

2015; Zhang et al., 2012), we hypothesized that the reduced synaptic levels of Hsc70-4 induced by wild-type and mutant TDP-43
may impair synaptic function.
We have previously shown that OE of wild-type or mutant
TDP-43 decreases the number of synaptic boutons at larval
NMJs (Coyne et al., 2014; Estes et al., 2013) and increases bouton size (Figures S4Q and S4R), similar to mutations that affect
SV endocytosis (Verstreken et al., 2002). We did not observe a

reduction in the number of active zones for neurotransmitter
release per bouton area when TDP-43 was expressed in motor
neurons (Figures S4A–S4H). Furthermore, TDP-43 OE in motor
neurons did not alter the intensity or area occupied by Csp within
synaptic boutons (Figures S4I–S4P), suggesting that the total
number of SVs was within normal range.
To test whether wild-type or mutant TDP-43 OE in motor neurons affects synaptic transmission, we recorded spontaneous
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and evoked excitatory postsynaptic potentials (EPSPs) from
larval NMJs of muscle 6. In comparison to controls, neither
TDP-43WT nor TDP-43G298S OE had an effect on spontaneous
or stimulus-evoked EPSP amplitudes (Figures 3D–3F). Accordingly, quantal content of evoked neurotransmitter release was
normal (Figure 3G).
Next, we examined SVC by performing FM1-43 dye uptake assays at the larval NMJ (see Experimental Procedures; Kuromi
and Kidokoro, 2005). In comparison to controls, TDP-43WT and
TDP-43G298S OE significantly reduced K+-induced FM1-43 dye
uptake by 33% ± 1.8% and 39% ± 2.1%, respectively (p <
0.001; Figures 3H–3J and 3Q). Subsequent K+ stimulation to unload FM1-43 dye from boutons showed no difference between
TDP-43 mutant NMJs and controls (Figures S5A–S5C). Taken
together, these results indicate that TDP-43 OE does not affect
exocytosis but causes defects in SV endocytosis.
The Chaperone Activity of Hsc70-4 Is Required to
Mitigate SVC Defects Caused by TDP-43G298S
We next asked whether Hsc70-4 OE can mitigate TDP-43induced defects in FM1-43 dye uptake. When OE was in a
wild-type background or together with TDP-43WT, Hsc70-4
had no effect on FM1-43 dye uptake at the NMJ (p > 0.05; Figures 3K, 3L, and 3Q). In contrast, co-OE of Hsc70-4 with TDP43G298S strongly suppressed the defects in FM1-43 dye uptake
induced by TDP-43G298S OE (p < 0.001; Figures 3M and 3Q).
To determine whether the chaperone activity of Hsc70-4 is
required for its protective effect, we co-overexpressed chaperone-dead Hsc70-4 (Hsc70-4D10N; Uytterhoeven et al., 2015),
and we found that it does not alter FM1-43 dye uptake deficits
induced by TDP-43 (p > 0.05; Figures 3O–3Q). It also had no effect on its own when OE was in a wild-type background (p > 0.05;
Figures 3N and 3Q). These data suggest that TDP-43WT OE induces SV endocytosis defects that are, at least in part, independent of Hsc70-4. In contrast, mutant TDP-43G298S induces defects in SV endocytosis that are mechanistically linked to the
chaperone activity of Hsc70-4.
Auxilin OE or RNAi-Mediated Knockdown Does Not Alter
TDP-43 Locomotor Phenotypes
Hsc70’s molecular chaperone activity critically requires DNAJ
proteins, which transition Hsc70-ATP to the ADP-bound state
to stabilize client interactions (Jiang et al., 2007; Kampinga and
Craig, 2010). At synaptic terminals, Hsc70’s chaperone function
in SV exo- and endocytosis is facilitated by the DNAJ proteins
auxilin and Csp on SVs (Kampinga and Craig, 2010; Liu et al.,
2012; Zinsmaier and Bronk, 2001). To determine the mechanisms underlying Hsc70-4-dependent phenotypes of TDP-43
OE, we used larval turning assays to examine the effects of mutations affecting critical steps of SVC (Figure 4A).
We first tested whether TDP-43 OE impairs auxilin/Hsc70mediated clathrin uncoating of SV. Auxilin OE or RNAi-mediated
knockdown (55% decrease in expression by qPCR, data not
shown) had no effect on larval turning on its own or in combination with wild-type and mutant TDP-43 (Figures 4B and 4C). This
suggests that the synaptic defects induced by wild-type or
mutant TDP-43 OE are unlikely due to a compromised auxilin/
Hsc70 clathrin-uncoating activity.
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Csp Levels and Chaperone Activity Modulate TDP-43Mediated Locomotor Dysfunction
Next, we tested for genetic interactions with Csp, which recruits
Hsc70-4 to a chaperone complex on SVs, ensuring proper assembly of SNARE and dynamin complexes during SV exo- and endocytosis, respectively (Chandra et al., 2005; Tobaben et al., 2001;
Zhang et al., 2012; Zinsmaier, 2010). OE of Csp in a wild-type
background from a genomic transgene (increasing Csp gene
dosage by one copy) (Zinsmaier et al., 1994) had no effect on larval
turning time (Figure 4D), while co-OE with TDP-43WT or TDP43G298S restored larval turning time to control levels (Figure 4D).
OE of Csp with a UAS transgene had a significant effect on larval
turning time on its own (data not shown), likely due to high levels of
Csp causing neurodegeneration (Nie et al., 1999); therefore, we
did not pursue this line for further genetic interactions with TDP-43.
Csp’s J domain promotes the ATPase activity of both Hsc70
and Hsp70, which is abolished by mutations in the HPD
motif and J domain (Braun et al., 1996; Bronk et al., 2005; Chamberlain and Burgoyne, 1997; Zhang et al., 1999). OE of J domain
mutant CspH45Q alone (Bronk et al., 2005) had no effect on larval
turning (Figure 4E); however, co-OE with TDP-43WT or TDP43G298S strongly enhanced locomotor dysfunction (Figure 4E).
Taken together, these results suggest that OE of wild-type or
mutant TDP-43 impairs the activity of the Csp/Hsc70-4 chaperone complex.
OE of Csp/Hsc70-4’s Client Dynamin Mitigates TDP-43Induced Locomotor Dysfunction
Csp/Hsc70-4 chaperone activity maintains SV endocytosis by
ensuring proper oligomerization of the GTPase dynamin (Rozas
et al., 2012; Zhang et al., 2012). Once a critical mass is reached,
oligomerization activates dynamin’s GTPase activity, which in
turn pinches or pops off newly formed SVs from the plasma
membrane (Haucke et al., 2011; Jahn and Fasshauer, 2012;
Ramachandran, 2011). To determine whether TDP-43 OE affects
Csp/Hsc70-4’s chaperone activity on dynamin, we tested
whether OE of Drosophila dynamin (shibire) may restore TDP43-induced locomotor defects, and we found that, while OE of
shibire alone had no effect on larval turning (Figure 4F), co-OE
with TDP-43WT or TDP-43G298S in motor neurons restored locomotor function (Figure 4F). Notably, none of the mRNAs encoding the examined SVC proteins was enriched in wild-type or
mutant TDP-43 complexes or were translationally dysregulated,
as suggested by polysome fractionations (Figure S6).
OE of Hsc70-4’s Co-chaperone Csp or Its Client
Dynamin Suppresses SVC Defects Induced by TDP-43 in
Motor Neurons
To determine whether OE of Hsc70-4’s co-chaperone Csp or their
client dynamin can mitigate TDP-43-dependent defects in SVC,
we tested if the genomic Csp construct or dynamin OE can
restore FM1-43 dye uptake defects induced by TDP-43. We
found that OE of either Csp from a genomic transgene or dynamin
alone had no effect on K+-induced FM1-43 dye uptake in comparison to control (p > 0.05; Figures 4J, 4M, and 4P). Co-OE of Csp
fully restored the defect in FM1-43 dye uptake induced by TDP43WT or TDP-43G298S OE (Figures 4G–4I) to control levels (Figures
4K, 4L, and 4P). Similarly, co-OE of dynamin also fully suppressed

Figure 4. Factors Involved in Hsc70-4-Independent and -Dependent Steps of SVC Modulate TDP-43 Toxicity
(A) Diagram of the SV cycle.
(B–F) Motor neuron expression of TDP-43 WT or G298S results in increased larval turning time, which is enhanced upon OE of the Csp J domain mutant CspH45Q
(E) and suppressed upon genomic expression of Csp (D) or OE of dynamin (shibire, F). OE (B) or reduction in auxilin (Auxilin RNAi, C) does not alter TDP-43mediated locomotor defects.
(G–O) Confocal images of FM1-43 dye uptake after 5 min of stimulation in HL-3 saline containing 90 mM KCl and 2 mM Ca2+. Genotypes are indicated on the top
and left.
(P) Quantification of FM1-43 dye uptake normalized to total FM1-43 uptake area.
All data shown are mean ± SEM. Scale bar, 10 mm (G).

the defect in FM1-43 dye uptake to control levels (Figures 4N–4P).
Taken together, these data suggest that OE of wild-type or mutant
TDP-43 impairs the activity of the Csp/Hsc70 complex in maintaining normal dynamin function for SV endocytosis.
OE of Hsc70-4 Attenuates the Aggregation of TDP-43WT
but Not TDP-43G298S
Given the general role of Hsc70-4 in clearance of misfolded or
aggregated proteins (Liu et al., 2012; Stricher et al., 2013; Zetter-

ström et al., 2011), we hypothesized that Hsc70-4 OE may
influence TDP-43 aggregation. To examine this, we performed
subcellular fractionations from Drosophila larvae co-overexpressing wild-type or mutant TDP-43 with Hsc70-4 in motor neurons, and we quantified the amount of TDP-43 in the soluble
(low-salt [LS]), sarkosyl (Sark), and urea (Urea) fractions. Interestingly, Hsc70-4 co-OE significantly reduced the amount of
TDP-43WT in the Urea fraction and increased the amount of
TDP-43WT in the Sark fraction (p < 0.01 and p < 0.05 respectively;
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Figure 5. TDP-43WT Insolubility Is Reduced by OE of Hsc70-4, and Hsc70-4 Insolubility Is Increased in an Age-Dependent Manner
(A and B) Solubility studies of third-instar larvae show the distribution of TDP-43WT (A) and TDP-43G298S (B) in low-salt (LS)-, sarkosyl (Sark)-, and Urea-containing
fractions alone and in the context of Hsc70-4 OE.
(C) Solubility studies of third-instar larvae show Hsc70-4 distribution in LS, Sark, and Urea fractions.
(D) Solubility studies of 7-day-old adults show Hsc70-4 distribution in LS, Sark, and Urea fractions.
(E) Quantification of TDP-43WT and TDP-43G298S levels in LS, Sark, and Urea fractions, normalized to input.
(F) Quantification of Hsc70-4 levels in LS, Sark, and Urea fractions from larval fractionations, normalized to input.
(G) Quantification of Hsc70-4 levels in LS, Sark, and Urea fractions from adult fractionations, normalized to input.

Figures 5A and 5E). Notably, Hsc70-4 OE had no significant effect on the solubility of ALS-associated mutant TDP-43G298S
(Figures 5B and 5E), despite its neuroprotective effects on
TDP-43G298S-induced functional phenotypes (Figures 3A–3C
and 3H–3M).
Conversely, TDP-43WT or TDP-43G298S OE in motor neurons
did not affect the solubility of endogenous Hsc70-4 at the larval
stage (Figures 5C and 5F). However, adult flies (7 days) exhibited
a significant increase in insoluble Hsc70-4 protein for both wildtype and mutant TDP-43 (p < 0.001; Figures 5D and 5G). Adults
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expressing TDP-43WT also showed a corresponding decrease of
Hsc70-4 protein in the Sark fraction in comparison to controls
(p < 0.001; Figures 5D and 5G). These data suggest an agedependent sequestration of Hsc70-4 by insoluble cytoplasmic
RNA/protein complexes, as previously observed in sporadic
ALS patient samples (Watanabe et al., 2001).
Co-OE of Hsc70-4 with TDP-43WT significantly decreased the
amount of insoluble Hsc70-4 in the Urea fraction (p < 0.001;
Figures 5D and 5G) and increased the amount of Hsc70-4
in the Sark fraction compared to TDP-43WT expression alone

(p < 0.001; Figures 5D and 5G), mirroring the effects of Hsc70-4
OE on TDP-43WT solubility. Thus, these data suggest that OE of
Hsc70-4 may mitigate TDP-43WT toxicity by improving the solubility of both TDP-43 and Hsc70.
C9orf72 Repeat Expansions Reduce Hsc70-4/HSPA8
Levels and Induce Defects in SVC
We next sought to determine whether similar SVC defects were
present in C9orf72 (C9) repeat expansion models (DeJesus-Hernandez et al., 2011; Renton et al., 2011). Using a fly model of C9
ALS (Mizielinska et al., 2014) containing 36 G4C2 repeats, we detected no alterations in Hsc70-4 expression in dissected VNCs
(Figures 6A and 6B). However, at synaptic boutons of larval
NMJs, Hsc70-4 levels were significantly decreased compared
to controls (21%, p < 0.001; Figures 6E–6G). There was no
change in hsc70-4 mRNA transcript levels in VNCs or NMJ preparations (Figures 6C and 6D), and Hsc70-4 protein levels in muscles were normal (Figure 6H). Together, these data indicate that
OE of G4C2 repeats impairs Hsc70-4 protein expression posttranscriptionally and cell autonomously in motor neurons.
To determine if HSPA8 expression was altered in a human C9
model of ALS, we used iPSC-derived motor neurons. In comparison to controls, HSPA8 levels were reduced in the soma and
dendrites of C9 iPSC motor neurons by 57% and 32%, respectively (p < 0.001; Figures 6I and 6J). Similar to the fly model, there
was no significant change in hsc70-4 mRNA in C9 iPSC motor
neurons compared to controls (Figure 6K). This suggests that
Hsc70 expression is post-transcriptionally downregulated in
C9 ALS human motor neurons.
Since the reduction in Hsc70-4 levels in C9 models of ALS is
reminiscent of that seen in the TDP-43 fly model, we hypothesized that C9 repeat expansions may also disrupt SVC. To test
this possibility, we performed FM1-43 dye uptake experiments
at the fly NMJ. OE of 36 G4C2 repeats in motor neurons significantly decreased FM1-43 dye uptake compared to G4C2 3X controls (53% ± 4.4%, p < 0.001; Figures 6L and 6M). To determine
the contribution of reduced synaptic expression of Hsc70-4 to
SVC deficits, we co-overexpressed Hsc70-4, and we found
that it restores FM1-43 dye uptake in flies expressing expanded
G4C2 repeats back to control levels (Figures 6L and 6M). These
data indicate that C9-mediated FM1-43 dye uptake deficits
are, at least in part, the result of decreased Hsc70-4 expression
at the NMJ. Furthermore, these findings suggest that both
TDP-43 and C9orf72 models of ALS share common features of
post-transcriptionally reduced Hsc70 expression levels that are
accompanied by defects in SVC.
DISCUSSION
ALS is a synaptopathy like other neurodegenerative disorders,
including Parkinson’s and Alzheimer’s diseases (Gillingwater
and Wishart, 2013). However, the mechanisms underlying synaptic dysfunction and neurodegeneration remain poorly understood. TDP-43 has been linked to a majority of ALS cases and
is known to associate with RNA SGs, which sequester specific
mRNAs and reduce their translation during stress (Dewey
et al., 2011; Kim et al., 2014; Liu-Yesucevitz et al., 2010; McDonald et al., 2011). Collectively, these studies have suggested that

TDP-43 association with RNA SGs plays a critical role in maintaining both proteostasis and ribostasis by controlling the
expression of target mRNAs and sequestration of protein partners. Because of its central role in ALS pathogenesis, understanding the molecular mechanisms underlying TDP-43-mediated neurodegeneration and defining its mRNA targets and
their mode of regulation are expected to provide a deeper understanding of disease pathophysiology and identify novel therapeutic targets.
Distinct Mechanisms Govern TDP-43-Dependent
Toxicity and Regulation of Hsc70-4 Expression
Using a Drosophila model of ALS based on TDP-43, we show
that OE of ALS-associated mutant TDP-43 in motor neurons sequesters hsc70-4 mRNA and reduces synaptic Hsc70-4 protein
levels at larval NMJs. HSPA8 expression is also reduced in cell
bodies and growth cones of cultured primary motor neurons,
at NMJs of mice expressing mutant TDP-43, and in human
iPSC motor neurons, suggesting that the relationship between
TDP-43 and Hsc70 is evolutionarily conserved.
TDP-43WT OE in fly motor neurons also leads to a post-transcriptional reduction of synaptic Hsc70-4 levels at larval NMJs.
However, IPs and cellular fractionations suggest that this is unlikely due to hsc70-4 mRNA sequestration and reduced translation. It is possible that the sensitivity of this assay is limited or that
subtle defects in other aspects of RNA or protein processing
result in reduced Hsc70-4 protein expression at the NMJ. Supporting this, bioinformatics analyses of published crosslinking
IP (CLIP) data suggest that endogenous TDP-43 can bind
HSPA8 introns and exons in mouse brains and human K562 cells
(Polymenidou et al., 2011; Van Nostrand et al., 2016) (Figure S7).
Hsc70 belongs to a neuroprotective synaptic network that
maintains SV exo- and endocytosis and prevents neurodegeneration (Bronk et al., 2001; Chang et al., 2002; Zinsmaier, 2010;
Zinsmaier and Bronk, 2001). This led us to hypothesize that alterations in Hsc70-4 expression may be detrimental to synaptic
function. Indeed, using a combination of FM1-43 dye loading
and unloading experiments together with electrophysiology,
we find that OE of TDP-43WT or TDP-43G298S in motor neurons
leads to defects in SV endocytosis, but not exocytosis. Although
loss of endogenous fly TDP-43 (TBPH) has been shown to cause
reduced expression of the synaptic proteins Syntaxin (Romano
et al., 2014) and Cacophony (Chang et al., 2014) at the NMJ,
and defects in SVC have been previously described in Parkinson’s disease (Xu et al., 2016), here we provide mechanistic insights into reduced SV endocytosis at the NMJ, in the context
of TDP-43 toxicity.
In the case of mutant TDP-43, co-OE of Hsc70-4 provides significant rescue of the FM1-43 dye uptake defect, although we
note that this is not a full restoration to the levels observed in controls. Co-OE of chaperone-dead Hsc70-4D10N fails to mitigate
TDP-43G298S-induced FM1-43 dye uptake defects, suggesting
that motor neuron expression of mutant TDP-43 reduces
Hsc70-4 levels below a threshold that is necessary to maintain
a molecular chaperone activity facilitating SV endocytosis/
cycling.
In contrast, for TDP-43WT, co-OE of Hsc70-4, while not sufficient to rescue SVC, appears to mitigate toxicity by generally
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Figure 6. C9orf72 Repeat Expansions Cause Reduced Hsc70-4/HSPA8 Expression and Defects in SVC
(A) WB for Hsc70-4 levels in VNCs of G4C2-expressing larvae. Genotypes are indicated on the bottom. Actin was used as a loading control.
(B) Quantification of Hsc70-4 protein levels from WBs represented as a ratio to G4C2 3X controls.
(C) qPCR for hsc70-4 mRNA in VNCs from animals expressing G4C2 36X in motor neurons versus G4C2 3X controls.
(D) qPCR for hsc70-4 mRNA in NMJ preparations from animals expressing G4C2 36X in motor neurons versus G4C2 3X controls.
(E and F) Single confocal sections of synaptic boutons in NMJ preparations immunostained for Hsc70-4 and the neuronal membrane marker Hrp from larvae
expressing G4C2 36X (F) compared to G4C2 3X controls (E). Antibodies are indicated on the left.
(G) Quantification of Hsc70-4 intensity in synaptic boutons, normalized to bouton area.
(H) Quantification of Hsc70-4 intensity in muscle, normalized to muscle area.
(I) Confocal images of control and C9 ALS human iPSC motor neurons immunostained for DAPI, the dendritic marker Map2, and Hsc70/HSPA8. Genotypes are
indicated on the left and antibodies are indicated on the top.
(J) Quantification of Hsc70/HSPA8 intensity in the soma and dendrites of control and C9 ALS human iPS motor neurons.
(K) qPCR for Hsc70/HSPA8 mRNA in control and C9 ALS human iPS motor neurons.
(L) Confocal images of FM1-43 dye uptake at Drosophila NMJs after 5 min of stimulation in HL-3 saline containing 90 mM KCl and 2 mM Ca2+. Genotypes are
indicated on the top and left.
(M) Quantification of FM1-43 dye uptake, normalized to total FM1-43 uptake area.
All data shown are mean ± SEM. Scale bars, 5 and 1 mm (E and F) and 10 mm (I and L).
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improving proteostasis and specifically reducing the aggregation of TDP-43WT itself, which correlates with improved locomotor function and increased lifespan. This suggests that the mechanism by which TDP-43WT and TDP-43G298S cause defects in
FM1-43 dye uptake is, at least in part, distinct; but, ultimately,
reduced Hsc70-4 levels at the NMJ impact the activity of its
co-chaperone complexes and clients, many of which control
critical steps in SVC.
Perturbations in the SV Cycle Highlight Key TDP-43Dependent Functional Interactions between Hsc70-4
Co-chaperone and Client Partners
Co-OE of Csp, an Hsc70-4 co-chaperone critical for stabilizing
client binding (Jiang et al., 2007; Kampinga and Craig, 2010), restores FM1-43 dye uptake to control levels for both TDP-43WT
and TDP-43G298S. This is surprising given that Hsc70-4 co-OE
mitigated the effects of TDP-43G298S but failed to rescue TDP43WT-mediated defects in endocytosis. A reasonable explanation for this result is that Csp has synaptic functions that are independent of Hsc70-4, as previously suggested (Bronk et al.,
2005). These additional functions may contribute to improved
SVC when Csp and TDP-43WT are co-overexpressed in motor
neurons. Co-OE of the GTPase dynamin, a client of the Csp/
Hsc70-4 chaperone complex (Zhang et al., 2012), also significantly restores FM1-43 dye uptake to control levels for wildtype and mutant TDP-43. Together, these findings are consistent with a scenario whereby TDP-43 impairs the activity of
the Csp/Hsc70 chaperone complex to maintain normal dynamin
function.
Toward a Common, Synaptic Pathomechanism of
Disease
Similar to what we found for TDP-43, we show that HSPA8
expression is reduced at synaptic terminals of C9 repeat-expressing flies and in cell bodies and dendrites of human C9
iPSC motor neurons. Furthermore, we show that C9 repeat expansions in flies lead to defects in FM1-43 dye uptake. However, the precise mechanism by which C9 repeat expansions
regulate Hsc70 expression and SVC remains to be determined.
As previous studies have reported a decrease in excitatory
junction potential (EJP) amplitude and quantal content in a fly
model of C9 ALS (Zhang et al., 2015), it is possible that C9mediated reduced synaptic expression of Hsc70 may elicit
FM1-43 dye uptake defects that arise due to deficits in both
SV exo- and endocytosis. Recent reports suggest that splicing
and transcriptome alterations, including changes in synaptic
gene expression, contribute to C9 ALS pathology (CooperKnock et al., 2015; Prudencio et al., 2015). Thus, it is likely
that multiple mechanisms may be at play to alter SVC in C9mediated ALS.
Although OE of either TDP-43WT or disease-associated TDP43G298S leads to similar phenotypes, our findings of hsc70-4
mRNA as a mutant-specific sequestration and translation target
suggest that the molecular mechanisms utilized by different
TDP-43 variants are, at least in part, distinct (see Figure 7).
This knowledge could impact the development of therapeutic
strategies that ought to take into consideration the specific
mechanisms of toxicity associated with TDP-43WT, which is

linked to 97% of ALS cases, as opposed to ALS-associated
mutant TDP-43 that only represents 2%–3% of ALS cases.
Taken together, our data suggest that post-transcriptional dysregulation of Hsc70-4 expression connects defects in ribostasis
and proteostasis at synapses in ALS across multiple models.
Improving SVC through OE of Hsc70, its co-chaperone Csp, or
their client dynamin highlights the SV cycle as a unifying therapeutic target in ALS and related neurodegenerative disorders,
such as frontotemporal dementia (FTD) and Alzheimer’s disease,
in which TDP-43 pathology has been reported.
EXPERIMENTAL PROCEDURES
Drosophila Genetics
All Drosophila stocks and crosses were kept on standard yeast/cornmeal/
molasses food at 22 C unless otherwise noted.
Larval Turning Assays
Wandering third-instar larvae were placed on a grape juice plate. After a 30-s
acclimation, larvae were gently turned ventral side up and observed until they
turned over and began making a forward motion.
Lifespan Analysis
Newly eclosed males and females (100 per genotype) were separated and
placed in a new vial every 7 days. Survival plots were generated using R and
RStudio.
Electrophysiology
Current-clamp recordings were made from muscle 6 of third-instar larvae
using a modified Ca2+ free HL-3 saline, as described (Dawson-Scully et al.,
2000).
FM1-43 Dye Uptake Assays
FM1-43 dye uptake assays using 4 mM FM1-43FX, 90 mM KCl, and 2 mM Ca2+
for stimulation were adapted from Kuromi and Kidokoro (2005) and Verstreken
et al. (2008).
Cellular Fractionations and Western Blotting
Cellular fractionations were previously described (Estes et al., 2013; Liachko
et al., 2010).
Western blots (WBs) were performed as described (Coyne et al., 2014,
2015). Primary antibodies were 1:3,000 rabbit Anti-Hsc70-4 (from K. Zinsmaier), 1:6,000 rabbit Anti-GFP (Invitrogen), and 1:5,000 rabbit Anti-b-actin (Cell
Signaling Technology).
IPs
IPs were performed using published protocols (Coyne et al., 2014).
Polysome Fractionations
Polysome fractionations were previously described (Coyne et al., 2014, 2015).
Real-Time qPCR
Real-time qPCR is described in the Supplemental Experimental Procedures.
An RNeasy kit (QIAGEN) was used for RNA isolation. First-strand cDNA
synthesis was performed with a Superscript III cDNA synthesis kit (Invitrogen). qPCR reactions were carried out using SYBR Select Master Mix
(Applied Biosystems) and an ABI 7300 Real Time PCR System (Applied
Biosystems).
Immunohistochemistry and Confocal Imaging
Larval NMJs were prepared as described (Estes et al., 2011, 2013). Primary
antibodies were 1:50 rabbit Anti-Hsc70-4 (from K. Zinsmaier), 1:300 mouse
Anti-DCSP2 (DSHB), and 1:50 mouse Anti-Bruchpilot, NC82 (DSHB).
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Figure 7. A Model for TDP-43 and Hsc70-4 Interactions
(A) In controls, TDP-43 does not sequester mRNA targets or protein partners, leading to normal levels of mRNA translation and synaptic proteins at the NMJ. As a
result, SVC occurs as normal.
(B) Motor neuron expression of TDP-43 results in decreased synaptic expression of Hsc70-4 and defects in SV endocytosis. Mutant TDP-43 sequesters hsc70-4
mRNA in insoluble complexes and inhibits its translation. Note post-transcriptional reduction in Hsc70 expression and SVC deficits are also present in C9orf72
models of ALS.
Primary Neuron Cultures: Transfection, Staining, Image Acquisition,
and Analysis
All procedures for animal experiments were approved by the Emory University
Institutional Animal Care and Use Committee (IACUC) and the Emory University Institutional Review Board. Primary motor neurons from spinal cords of
mouse embryos were isolated and plated at day 13.5 (Fallini et al., 2010).
Human iPSC Motor Neuron Differentiation and
Immunocytochemistry for Hsc70/HSPA8
Control iPSCs and C9 iPSCs (>30 repeats) were differentiated to motor neurons as described by previous studies (Donnelly et al., 2013; Zhang et al.,
2015).
Mouse NMJs
Animal lines and procedures are described in the Supplemental Experimental
Procedures. All procedures were approved by the University of Kansas Medical Center IACUC. Immunohistochemistry, image analysis, and statistics were
described in Chen et al. (2011, 2012) and Nishimune et al. (2004).
Bioinformatics Analyses
See the Supplemental Experimental Procedures.
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Statistical Analyses
Larval turning assays used 30 larvae/genotype. Lifespan analysis used 100
flies/genotype. At least 6 animals/genotype were used for electrophysiology.
FM1-43 dye uptake experiments were performed on 12 animals, and a total
of 24 NMJs (2/animal) were used for analysis. Cellular fractionation, IPs,
WBs, polysome fractionations, and qPCR were performed in triplicate. For
analysis of mouse primary motor neurons, cell bodies and 10-mm segments
of the axonal growth cones were analyzed (cell body: GFP n = 57, TDP-43
WT n = 49, TDP-43 Q331K n = 42, and TDP-43 M337V n = 49; growth cone:
GFP n = 30, TDP-43 WT n = 24, TDP-43 Q331K n = 35, and TDP-43 M337V
n = 36). For immunocytochemistry in TDP-43 iPSC motor neurons, two control
lines and two differentiations of one TDP-43 line were used. For immunocytochemistry in C9orf72 iPSC motor neurons, one control line and one C9 line
were used. Statistical analyses were performed using the appropriate t test
or ANOVA model with Tukey’s post hoc test. For cellular fractionations,
Fisher’s test was used. Statistics were performed using GraphPad Prism software version 7.0. Lifespan statistical analysis was done using the log-rank test
in R. All data shown are mean ± SEM (*p < 0.05, **p < 0.01, and ***p < 0.001;
n.s., not significant).
Additional details on fly lines, iPSC demographic information, and experimental procedures can be found in the Supplemental Experimental
Procedures.
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